3rd Annual Dpharm: Disruptive Innovations to Advance Clinical Trials
19 Sep 2013 - 20 Sep 2013 - Boston, MA, USA
This conference creates a community for Chief Medical Officers of emerging biotechs with key responsibilities to execute and manage R&D. It particularly targets CMOs who make decisions about clinical outsourDesigned for drug development, innovative thinkers who are determined to re-invent clinical trials, this is an outcomes-focused program, not only delving deeply into the key strategic factors impeding clinical trial productivity, but also endeavoring to connect change makers who can share current solutions, propose new solutions and commit to testing them and sharing the results. It is designed to be extremely engaging in a highly informative format, similar to the style of TED events. Each session delivers a clear set of objectives, summary and well-defined, tangible takeaways.cing management as well as the creation and development of exit strategies. This conference will bring together CMOs, VCs and CROs.